SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028723
Filing Date
2021-05-18
Accepted
2021-05-18 16:38:58
Documents
93
Period of Report
2021-04-04

Document Format Files

Seq Description Document Type Size
1 10-Q ocdx-10q_20210404.htm   iXBRL 10-Q 2479486
2 EX-31.1 ocdx-ex311_178.htm EX-31.1 22570
3 EX-31.2 ocdx-ex312_177.htm EX-31.2 23044
4 EX-32.1 ocdx-ex321_175.htm EX-32.1 8096
5 EX-32.2 ocdx-ex322_176.htm EX-32.2 8142
  Complete submission text file 0001564590-21-028723.txt   10242145

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocdx-20210404.xsd EX-101.SCH 71327
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocdx-20210404_cal.xml EX-101.CAL 60727
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocdx-20210404_def.xml EX-101.DEF 303709
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocdx-20210404_lab.xml EX-101.LAB 472416
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocdx-20210404_pre.xml EX-101.PRE 477599
11 EXTRACTED XBRL INSTANCE DOCUMENT ocdx-10q_20210404_htm.xml XML 2038647
Mailing Address 1001 ROUTE 202 RARITAN NJ 08869
Business Address 1001 ROUTE 202 RARITAN NJ 08869 (908) 218-8000
Ortho Clinical Diagnostics Holdings plc (Filer) CIK: 0001828443 (see all company filings)

IRS No.: 981151819 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39956 | Film No.: 21936608
SIC: 2835 In Vitro & In Vivo Diagnostic Substances